Hatef Massoumi
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Hepatitis C virus research 4
- Liver Diseases and Immunity 3
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Hilary I. Hertan (3 shared papers)Paul J. Gaglio (3 shared papers)Allan W. Wolkoff (2 shared papers)Jordan J. Karlitz (1 shared paper)John F. Reinus (1 shared paper)Paul Feuerstadt (1 shared paper)Milan M. Kinkhabwala (2 shared papers)Juan Pablo Rocca (1 shared paper)
- Journals
- Hepatology (3 papers)Gastrointestinal Endoscopy (2 papers)Hepatology Communications (1 paper)Journal of Hepatology (1 paper)Liver Transplantation (1 paper)
- Partner nations
- United StatesItalySaudi Arabia
In The Last Decade
Hatef Massoumi
20 papers receiving 382 citations
Peers
Comparison fields: 5 of 39
- Hepatology 222
- Infectious Diseases 99
- Pharmacology 17
- Microbiology 1
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Hatef Massoumi
This map shows the geographic impact of Hatef Massoumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatef Massoumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatef Massoumi more than expected).
Fields of papers citing papers by Hatef Massoumi
This network shows the impact of papers produced by Hatef Massoumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatef Massoumi. The network helps show where Hatef Massoumi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hatef Massoumi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 66 | |
| 2 | 2009 | 59 | |
| 3 | 2016 | 58 | |
| 4 | 2021 | 56 | |
| 5 | 2007 | 40 | |
| 6 | 2021 | 33 | |
| 7 | 2022 | 17 | |
| 8 | 2020 | 14 | |
| 9 | 2009 | 13 | |
| 10 | 2017 | 10 | |
| 11 | 2020 | 8 | |
| 12 | 2011 | 6 | |
| 13 | 2016 | 5 | |
| 14 | Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population. | 2016 | 4 |
| 15 | 2013 | 2 | |
| 16 | 2004 | 1 | |
| 17 | 2004 | 1 | |
| 18 | 2006 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2015 | 1 |
About Hatef Massoumi
Hatef Massoumi is a scholar working on Hepatology, Infectious Diseases, Pharmacology, Surgery and Gastroenterology, having authored 22 papers that have together received 398 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Hepatitis C virus research (4 papers), Liver Diseases and Immunity (3 papers), Hepatitis B Virus Studies (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Gallbladder and Bile Duct Disorders (2 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hepatology (222 citations), Infectious Diseases (99 citations), Pharmacology (17 citations), Microbiology (1 citation) and Pulmonary and Respiratory Medicine (34 citations). Hatef Massoumi has collaborated with scholars based in United States, Italy and Saudi Arabia. Frequent co-authors include Hilary I. Hertan, Paul J. Gaglio, Allan W. Wolkoff, Jordan J. Karlitz, John F. Reinus, Paul Feuerstadt, Milan M. Kinkhabwala, Juan Pablo Rocca, James M. Szymanski and Charissa Chang. Their work appears in journals such as Hepatology, Gastrointestinal Endoscopy, Hepatology Communications, Journal of Hepatology and Liver Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.